Increased risk of suicide under intrathecal ziconotide treatment? - A warning

Pain

Volumn 152, Issue 1, 2011, Pages 235-237

  Maier, Christoph ^a   Gockel, Hans Helmut ^b   Gruhn, Kai ^a   Krumova, Elena K ^a   Edel, Marc Andreas ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Medizinische Klinik   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Adverse effects; Depression; Intrathecal pain treatment; Suicide; Ziconotide

Indexed keywords

BUPRENORPHINE; DULOXETINE; ETORICOXIB; FLUOXETINE; FLUPIRTINE; MORPHINE SULFATE; NORSPAN; OMEGA CONOTOXIN MVIIA; OPIATE; PREDNISOLONE; PREGABALIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANALGESIA; APPETITE; ARTICLE; CASE REPORT; COCCYGEAL BONE; COGNITIVE DEFECT; DEPRESSION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOOT PAIN; HOSPITAL ADMISSION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOSPITAL DISCHARGE; HUMAN; LOADING DRUG DOSE; LOW BACK PAIN; LOW DRUG DOSE; MALE; NAUSEA; NEUROPATHIC PAIN; PAIN ASSESSMENT; PHYSIOTHERAPY; POLYNEUROPATHY; PRIORITY JOURNAL; RESTLESSNESS; RISK ASSESSMENT; SIDE EFFECT; SLEEP DISORDER; SPINAL CORD STIMULATION; SUICIDAL IDEATION; TASTE BUD; VERTEBRA FRACTURE; VERTIGO;

EID: 78650415529     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.10.007     Document Type: Article

References (28)

1. G. Bennett, K. Burchiel, E. Buchser, A. Classen, T. Deer, S. Du Pen, F.M. Ferrante, S.J. Hassenbusch, L. Lou, J. Maeyaert, R. Penn, R.K. Portenoy, R. Rauck, M. Serafini, K.D. Willis, and T. Yaksh Clinical guidelines for intraspinal infusion: report of an expert panel. PolyAnalgesic consensus conference J Pain Symptom Manage 20 2000 S37 S43
2. T. Deer, E. Krames, S. Hassenbusch, A.W. Burton, D. Caraway, and S. Du Pen Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intrathecal) drug delivery: report of an interdisciplinary expert panel Neuromodulation 10 2007 300 328
3. EMEA. Positive opinion for orphan designation of ziconotide. < http://www.ema.europa.eu/pdfs/human/comp/opinion/025204en.pdf > [accessed: 07.03.10].
4. FDA. Approval history. Label. < http://www.accessdata.fda.gov/Scripts/ cder/DrugsatFDA/index.cfm?fuseaction=Search.Label-ApprovalHistory > [accessed 06.03.10].
5. S.J. Hassenbusch, and R.K. Portenoy Current practices in intrathecal therapy - a survey of clinical trends and decision making J Pain Symptom Manage 20 2000 4 11
6. H.G. Kress, K.H. Simpson, P. Marchettini, A. Ver Donck, and G. Varrassi Intrathecal therapy: what has changed with the introduction of ziconotide Pain Pract 9 2009 338 347
7. T. Levin, G. Petrides, J. Weiner, S. Saravay, A.S. Multz, and S. Bailine Intractable delirium associated with ziconotide successfully treated with electroconvulsive therapy Psychosomatics 43 2002 63 66
8. K.A. Lyseng-Williamson, and C. Perry Ziconotide CNS Drugs 20 2006 331 338 [discussion 339-41]
9. T. Nickel, A. Sonntag, M. Backmund, and T. Pollmächer Depression during therapy with interferon alpha - how long should an antidepressant treatment last? Pharmacopsychiatry 38 2005 102 104
10. Prialt prescribing information; 2008. < http://www.prialt.com/Images/ product-information.pdf > [accessed: 01.03.10].
11. R. Rauck, M.S. Wallace, M.S. Leong, M. Minehart, L.R. Webster, and S.G. Charapata A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain J Pain Symptom Manage 31 2006 393 406
12. H. Saegusa, T. Kurihara, S. Zong, O. Minowa, A. Kazuno, W. Han, Y. Matsuda, H. Yamanaka, M. Osanai, T. Noda, and T. Tanabe Altered pain responses in mice lacking alpha 1E subunit of the voltage-dependent Ca2+ channel Proc Natl Acad Sci USA 97 2000 6132 6137
13. A. Schmidtko, J. Lötsch, R. Freynhagen, and G. Geisslinger Ziconotide for treatment of severe chronic pain Lancet 375 2010 1569 1577
14. J. Sharp, and B. Keefe Psychiatry in chronic pain: a review and update Curr Psychiatry Rep 7 2005 213 219
15. M.J. Skov, J.C. Beck, A.W. de Kater, and G.M. Shopp Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class Int J Toxicol 26 2007 411 421
16. H.S. Smith, and T.R. Deer Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain Ther Clin Risk Manage 5 2009 521 534
17. T.P. Snutch Targeting chronic and neuropathic pain: the N-type calcium channel comes of age NeuroRx 2 2005 662 670
18. P.S. Staats, T. Yearwood, S.G. Charapata, R.W. Presley, M.S. Wallace, and M. Byas-Smith Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial JAMA 291 2004 63 70
19. N.K. Tang, and C. Crane Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links Psychol Med 36 2006 575 586
20. J.C. Thompson, E. Dunbar, and R.R. Laye Treatment challenges and complications with ziconotide monotherapy in established pump patients Pain Physician 9 2006 147 152
21. M.O. Urban, K. Ren, M. Sablad, and K.T. Park Medullary N-type and P/Q-type calcium channels contribute to neuropathy-induced allodynia Neuroreport 16 2005 563 566
22. K. van Heeringen The neurobiology of suicide and suicidality Can J Psychiatry 48 2003 292 300 [Comment on: Can J Psychiatry 2003;48:289-91]
23. M.S. Wallace Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain Expert Rev Neurother 6 2006 1423 1428
24. M.S. Wallace, R. Rauck, R. Fisher, S.G. Charapata, D. Ellis, and S. Dissanayake Ziconotide 98-022 study group. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial Anesth Analg 106 2008 628 637
25. K.L. Webster Fakata, S. Charapata, R. Fisher, and M. Minehart Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain Pain Med 9 2008 282 290
26. J.A. Williams, M. Day, and J.E. Heavner Ziconotide: an update and review Expert Opin Pharmacother 9 2008 1575 1583
27. T. Yamamoto, and A. Takahara Recent updates of N-type calcium channel blockers with therapeutic potential for neuropathic pain and stroke Curr Top Med Chem 9 2009 377 395
28. N.A. Youssef, and C.L. Rich Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? A literature review Ann Clin Psychiatry 20 2008 157 169